Skip to content
2000

Anthraquinone-Based Nanomaterials: Emerging Strategies in Cancer Therapy

image of Anthraquinone-Based Nanomaterials: Emerging Strategies in Cancer Therapy
Preview this chapter:

Anthraquinone-based nanomaterials (ANMs) have recently garnered considerable attention due to their potential applications in cancer therapy. Anthraquinones are characterized by their tricyclic aromatic structure, which can be modified and incorporated into nanomaterials for various therapeutic purposes in cancer treatment. There are several ways in which ANMs are currently being investigated for cancer therapy such as improved drug delivery systems, photothermal therapy, photodynamic therapy, imaging agents (anti-cancer agents), combination therapy, and biomarker detection. It is important to highlight that ongoing research in the field of nanomedicine is continuously advancing, and the exploration of ANMs for cancer therapy is a rapidly evolving area. Recent studies reported in the literature show that ANMs effectively inhibit cancer by reactive oxygen species formation, paraptosis, autophagy, apoptosis, and various cell signaling pathways. Furthermore, before these ANMs can be extensively utilized in cancer therapy, regulatory approval and clinical trials are mandatory steps in the process. The chapter outlines a comprehensive overview of ANMs, highlighting their potential use for therapeutic, cancer therapy, and various health products.

/content/books/9789815313987.chapter-6
dcterms_subject,pub_keyword
-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData
10
5
Chapter
content/books/9789815313987
Book
false
en
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test